Fusion Pharmaceuticals
targeting fibroblast growth factor receptor a a | Fusion Pharmaceuticals
Company
Deck Type
IPO
Sector
Industry
Deck date
June 2020
Slide
38 of 49
Related slides by other companies
Truecaller
Results
May 2022
business highlights was one of the top most in the world and achieved the milestone of an to mau engagement ratio in strong growth in consumer advertising following continued growth in number of users in various geographies combined with an sequential improvement in ads revenue per user continuous high growth of for business in many industries in and other markets south partnership with for business messaging targeting messages in year acquisition of adding value and functionality for both android and ios different finalized a | Truecaller
Crocs
Investor Presentation
February 2022
targeting sandals revenue growth by | Crocs
Crocs
Investor Presentation
March 2022
targeting sandals revenue growth by | Crocs
Grab
Investor Day
September 2022
sustainable growth | Grab
Other recent decks by Fusion Pharmaceuticals
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights